LX4211, a dual inhibitor of SGLT2 and SGLT1 enhances the effects of sitagliptin in patients with type 2 diabetes mellitusB. Zambrowicz,I. Ogbaa,D. Powell,P. Banks,A. Turnage,K. Frazier,K. A. Boehm,J. Freiman,P. Lapuerta,D. Ruff,A. SandsDIABETOLOGIA(2012)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要